Pycnogenol® Trial Findings in Lipedema Patients (2025) Study Design •Type: Randomized, double-blind, placebo-controlled clinical trial. •Participants: 100 women aged 18–40 years with clinically diagnosed lipedema. •Intervention: Pycnogenol® 50 mg three times daily (total ~150 mg/day) vs placebo. •Duration: 60 days (about 2 months). •Outcomes Measured: Lipedema symptoms, quality of life (QuASiL questionnaire), body composition (bioimpedance), and patient-reported changes. 📊 Key Results Symptom R

Breaking News: First Placebo-Controlled Study Shows Alzheimer’s Reversal I just returned from the Precision Health & Medicine Conference, where one speaker shared details about a soon-to-be-published study in the Journal of Alzheimer’s Disease. It’s the first placebo-controlled trial showing measurable reversal of Alzheimer’s symptoms—using lifestyle, nutrition, and targeted supplements. This confirms what forward-thinking clinicians like Dr. Dale Bredesen and others have been seeing for years i